Author:
Zhu Rongrong,Wang Qingxiu,Zhu Yanjing,Wang Zhaoqi,Zhang Haixia,Wu Bin,Wu Xianzheng,Wang Shilong
Funder
National Natural Science Foundation of China
Fundamental Research Funds for the Central Universities
Subject
Molecular Biology,Biomedical Engineering,Biochemistry,Biomaterials,General Medicine,Biotechnology
Reference43 articles.
1. Global cancer statistics;Jemal;CA Cancer J. Clin.,2011
2. Initial evaluation of the patient with lung cancer: symptoms, signs, laboratory tests, and paraneoplastic syndromes: ACCP evidenced-based clinical practice guidelines (2nd edition);Spiro;Chest,2007
3. A prospective phase I/II study: combination chemotherapy with docetaxel and pemetrexed as second-line treatment in patients with stage IIIB/IV non-small cell lung cancer;Kroeber;Case Rep. Oncol.,2014
4. Clinical and cost effectiveness of paclitaxel, docetaxel, gemcitabine, and vinorelbine in non-small cell lung cancer: a systematic review;Clegg;Thorax,2002
5. Pemetrexed in advanced non-small-cell lung cancer;Fuld;Expert Opin. Pharmacother.,2010
Cited by
63 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献